Live from the NIH registry
Studies recruiting near New Bedford right now
Top 25 of 517 recruiting studies, sorted by proximity — each links to its official registry page
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Velocity Clinical Research, Providence (East Greenwich) — East Greenwich, Rhode Island (26.5 mi)
· Sponsor: AbbVie
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Providence, Rhode Island (26.5 mi)
· Sponsor: Daiichi Sankyo
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Alcohol Use Disorder (AUD)
Phase 2
Interventional 184 participants sought
Brown University — Providence, Rhode Island (26.5 mi)
· Sponsor: Brown University
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
University Orthopedics — Providence, Rhode Island (26.5 mi)
· Sponsor: International Spine Study Group Foundation
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Hasbro Children's Hospital - PIN — Providence, Rhode Island (26.5 mi)
· Sponsor: Takeda
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
Butler Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Washington University School of Medicine
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: NRG Oncology
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Lifespan Cancer Institute — Providence, Rhode Island (26.5 mi)
· Sponsor: Regeneron Pharmaceuticals
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Lucida Clinical Trials — New Bedford, Massachusetts (2.5 mi)
· Sponsor: Eli Lilly and Company
Follow-up Visit of High Risk Infants
Infant, Newborn, Infant, Low Birth Weight
N/A
Observational 68,000 participants sought
Brown University, Women & Infants Hospital of Rhode Island — Providence, Rhode Island (26.5 mi)
· Sponsor: NICHD Neonatal Research Network
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early Onset Alzheimer Disease, Alzheimer Disease
N/A
Observational 850 participants sought
Butler Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Indiana University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Providence Veterans Administration Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
2951, The Miriam Hospital (TMH) CRS — Providence, Rhode Island (26.5 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary
Phase 1, Phase 2
Interventional 200 participants sought
Women & Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Volastra Therapeutics, Inc.
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Nephrology Associates Inc — East Providence, Rhode Island (24.2 mi)
· Sponsor: Amgen
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fairhaven, Massachusetts (3.0 mi)
· Sponsor: AstraZeneca
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Relapsed/Refractory Primary Central Nervous System Lymphoma
Phase 3
Interventional 132 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
Alzheimer Disease, Early Onset, Mild Cognitive Impairment
Phase 1
Interventional 35 participants sought
Memory and Aging Program, Butler Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Butler Hospital
Cannabis' Impact on Alcohol Consumption
Alcohol Drinking, Cannabis Use
Phase 2
Interventional 350 participants sought
Brown University — Providence, Rhode Island (26.5 mi)
· Sponsor: Brown University
RCT of Pain Perception With Fast and Slow Tenaculum Application
Pain, Acute, Pain, Procedural
N/A
Interventional 150 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Women and Infants Hospital of Rhode Island
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Women & Infants Hospital of Rhode Island — Providence, Rhode Island (26.5 mi)
· Sponsor: Context Therapeutics Inc.